Prescription Drug Price Transparency Act

United States116e CongrèsHR-1035House of Representatives
Mis à jour : 7 févr. 2019

Résumé

Aucun résumé n’est disponible.

Textes du projet de loi

Versions disponibles
Introduced (House)Consulter le texte officiel

1 version disponible

Tous les dossiers disponibles sont affichés.

Chronologie

  1. Referred to the Subcommittee on Health.

    House of Representatives

  2. Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  3. Introduced in House

Tous les dossiers disponibles sont affichés.